{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:11:03Z","timestamp":1761549063575,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ackdjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1053\/j.ackd.2020.03.002","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T03:09:08Z","timestamp":1592190548000},"page":"120-127.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genetic and Protein Structural Evaluation of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy"],"prefix":"10.1053","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9218-9805","authenticated-orcid":false,"given":"Stephen J.","family":"Perkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ackd.2020.03.002_bib1","doi-asserted-by":"crossref","first-page":"370426","DOI":"10.1155\/2012\/370426","article-title":"Familial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects","volume":"2012","author":"Bu","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"4","key":"10.1053\/j.ackd.2020.03.002_bib2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney Int"},{"issue":"10095","key":"10.1053\/j.ackd.2020.03.002_bib3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.ackd.2020.03.002_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.ajkd.2015.03.040","article-title":"Glomerular diseases dependent on complement activation, including atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis, and C3 glomerulopathy: core curriculum","volume":"66","author":"Noris","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ackd.2020.03.002_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2016.99","article-title":"Anti-complement-factor H-associated glomerulopathies","volume":"12","author":"Durey","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"10.1053\/j.ackd.2020.03.002_bib6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/jmedgenet-2014-102498","article-title":"Factors determining penetrance in familial atypical haemolytic uraemic syndrome","volume":"51","author":"Sansbury","year":"2014","journal-title":"J Med Genet"},{"issue":"5","key":"10.1053\/j.ackd.2020.03.002_bib7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddi066","article-title":"Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32","volume":"14","author":"Esparza-Gordillo","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"3","key":"10.1053\/j.ackd.2020.03.002_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"European Working Party on Complement Genetics in Renal Diseases. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2020.03.002_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1053\/j.ackd.2020.03.002_bib10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2020.03.002_bib11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"issue":"9","key":"10.1053\/j.ackd.2020.03.002_bib12","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2215\/CJN.01640214","article-title":"Complement mutations in diacylglycerol kinase-epsilon-associated atypical hemolytic uremic syndrome","volume":"9","author":"Sanchez Chinchilla","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2020.03.002_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1681\/ASN.2013121339","article-title":"A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1\/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation","volume":"26","author":"Valoti","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ackd.2020.03.002_bib14","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00467-013-2560-2","article-title":"A novel hybrid CFHR1\/CFH gene causes atypical hemolytic uremic syndrome","volume":"28","author":"Eyler","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1053\/j.ackd.2020.03.002_bib15","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1371\/journal.pmed.0030431","article-title":"Atypical haemolytic uraemic syndrome associated with a hybrid complement gene","volume":"3","author":"Venables","year":"2006","journal-title":"Plos Med"},{"issue":"2","key":"10.1053\/j.ackd.2020.03.002_bib16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/ndt\/gfq658","article-title":"A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome","volume":"26","author":"Maga","year":"2011","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"10.1053\/j.ackd.2020.03.002_bib17","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1172\/JCI68280","article-title":"C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation","volume":"123","author":"Tortajada","year":"2013","journal-title":"J Clin Invest"},{"issue":"9743","key":"10.1053\/j.ackd.2020.03.002_bib18","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(10)60670-8","article-title":"Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis","volume":"376","author":"Gale","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ackd.2020.03.002_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1172\/JCI71866","article-title":"Complement factor H-related hybrid protein deregulates complement in dense deposit disease","volume":"124","author":"Chen","year":"2014","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1053\/j.ackd.2020.03.002_bib20","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2215\/CJN.09541010","article-title":"Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees","volume":"6","author":"Athanasiou","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2020.03.002_bib21","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ki.1986.278","article-title":"Deficiency in two brothers with atypical dense intramembranous deposit disease","volume":"30","author":"Levy","year":"1986","journal-title":"Kidney Int"},{"issue":"40","key":"10.1053\/j.ackd.2020.03.002_bib22","doi-asserted-by":"crossref","first-page":"25168","DOI":"10.1074\/jbc.272.40.25168","article-title":"Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism","volume":"272","author":"Ault","year":"1997","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1053\/j.ackd.2020.03.002_bib23","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1172\/JCI43343","article-title":"Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation","volume":"120","author":"Martinez-Barricarte","year":"2010","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1053\/j.ackd.2020.03.002_bib24","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1681\/ASN.2015040348","article-title":"A familial C3GN secondary to defective C3 regulation by complement receptor 1 and complement factor H","volume":"27","author":"Chauvet","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2020.03.002_bib25","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2020.03.002_bib26","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1681\/ASN.2015040385","article-title":"High-throughput genetic testing for thrombotic microangiopathies and C3 glomerulopathies","volume":"27","author":"Bu","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ackd.2020.03.002_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molimm.2016.01.010","article-title":"Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome","volume":"71","author":"Iatropoulos","year":"2016","journal-title":"Mol Immunol"},{"issue":"6","key":"10.1053\/j.ackd.2020.03.002_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4103\/0971-4065.134089","article-title":"Current concepts in C3 glomerulopathy","volume":"24","author":"Thomas","year":"2014","journal-title":"Indian J Nephrol"},{"issue":"7","key":"10.1053\/j.ackd.2020.03.002_bib29","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.1701695","article-title":"Statistical validation of rare complement variants provides insights into the molecular basis of atypical hemolytic uremic syndrome and C3 glomerulopathy","volume":"200","author":"Osborne","year":"2018","journal-title":"J Immunol"},{"issue":"7616","key":"10.1053\/j.ackd.2020.03.002_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Exome Aggregation C: analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"issue":"5","key":"10.1053\/j.ackd.2020.03.002_bib31","doi-asserted-by":"crossref","first-page":"e00146","DOI":"10.1042\/BSR20140117","article-title":"New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3","volume":"34","author":"Rodriguez","year":"2014","journal-title":"Biosci Rep"},{"issue":"1","key":"10.1053\/j.ackd.2020.03.002_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/humu.20268","article-title":"An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations","volume":"27","author":"Saunders","year":"2006","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1053\/j.ackd.2020.03.002_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/jmbi.2001.5337","article-title":"Molecular modelling of mutations in the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site","volume":"316","author":"Perkins","year":"2002","journal-title":"J Mol Biol"},{"issue":"2","key":"10.1053\/j.ackd.2020.03.002_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/gim.2016.90","article-title":"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples","volume":"19","author":"Walsh","year":"2017","journal-title":"Genet Med"},{"issue":"1","key":"10.1053\/j.ackd.2020.03.002_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13073-015-0138-2","article-title":"Rare variant association studies: considerations, challenges and opportunities","volume":"7","author":"Auer","year":"2015","journal-title":"Genome Med"},{"issue":"7","key":"10.1053\/j.ackd.2020.03.002_bib36","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ni.1755","article-title":"Structure of complement fragment C3b-factor H and implications for host\u00a0protection by complement regulators","volume":"10","author":"Wu","year":"2009","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1053\/j.ackd.2020.03.002_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nchembio.1696","article-title":"Structural basis for sialic acid-mediated self-recognition by complement factor H","volume":"11","author":"Blaum","year":"2015","journal-title":"Nat Chem Biol"},{"issue":"1","key":"10.1053\/j.ackd.2020.03.002_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jmb.2009.06.010","article-title":"Electrostatic interactions contribute to the folded-back conformation of wild type human factor H","volume":"391","author":"Okemefuna","year":"2009","journal-title":"J Mol Biol"},{"issue":"7058","key":"10.1053\/j.ackd.2020.03.002_bib39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nature04005","article-title":"Structures of complement component C3 provide insights into the function and evolution of immunity","volume":"437","author":"Janssen","year":"2005","journal-title":"Nature"},{"issue":"31","key":"10.1053\/j.ackd.2020.03.002_bib40","doi-asserted-by":"crossref","first-page":"12839","DOI":"10.1073\/pnas.1102167108","article-title":"Structural basis for complement factor I control and its disease-associated sequence polymorphisms","volume":"108","author":"Roversi","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1053\/j.ackd.2020.03.002_bib41","doi-asserted-by":"crossref","first-page":"e1001122","DOI":"10.1371\/journal.ppat.1001122","article-title":"Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens","volume":"6","author":"Persson","year":"2010","journal-title":"Plos Pathog"},{"issue":"44","key":"10.1053\/j.ackd.2020.03.002_bib42","doi-asserted-by":"crossref","first-page":"17166","DOI":"10.1074\/jbc.RA118.004767","article-title":"Two distinct conformations of factor H regulate discrete complement-binding functions in the fluid phase and at cell surfaces","volume":"293","author":"Osborne","year":"2018","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1053\/j.ackd.2020.03.002_bib43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nsmb.3427","article-title":"Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses","volume":"24","author":"Xue","year":"2017","journal-title":"Nat Struct Mol Biol"},{"issue":"11","key":"10.1053\/j.ackd.2020.03.002_bib44","doi-asserted-by":"crossref","first-page":"e0188127","DOI":"10.1371\/journal.pone.0188127","article-title":"Crystal structure of a tripartite complex between C3dg, C-terminal domains of factor H and OspE of Borrelia burgdorferi","volume":"12","author":"Kolodziejczyk","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1053\/j.ackd.2020.03.002_bib45","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201ckidney disease: Improving Global outcomes\u201d (KDIGO) Controversies conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559520300446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559520300446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:02:14Z","timestamp":1761548534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559520300446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1548559520300446"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2020.03.002","relation":{},"ISSN":["1548-5595"],"issn-type":[{"type":"print","value":"1548-5595"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic and Protein Structural Evaluation of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2020.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}